Live Breaking News & Updates on Vie Investor Relations

Stay updated with breaking news from Vie investor relations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genmab and AbbVie Announce Topline Results for Epcoritamab

Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to. ....

United States , North Chicago , New Jersey , Liz Shea , Ilke Limoncu , Mabel Martinez , Kalvebod Brygge , Marisol Peron , Mohamed Zaki , Andrew Carlsen , Global Oncology Development , Macrophage Properties Journal Of Immunology Baltimore , Exchange Commission , Hodgkin Lymphoma Research Foundation , Us National Library Of Medicine , Development Of Novel Anti , Global Investor Relations Communications , Company Announcement , Diffuse Large Lymphoma Research Foundation , Chief Executive Officer , Vice President , Allergan Aesthetics , Media Contact , Senior Vice President , Global Investor Relations , Investor Relations ,

Genmab A/S: Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Company Announcement Based on the topline results from the EPCORE NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to discuss next steps Data from the clinical ....

New Jersey , United States , Liz Shea , Ilke Limoncu , Mabel Martinez , Marisol Peron , Mohamed Zaki , Andrew Carlsen , Global Oncology Development , Macrophage Properties Journal Of Immunology Baltimore , Exchange Commission , Hodgkin Lymphoma Research Foundation , Us National Library Of Medicine , Development Of Novel Anti , Global Investor Relations Communications , Company Announcement , Diffuse Large Lymphoma Research Foundation , Chief Executive Officer , Vice President , Allergan Aesthetics , Annual Report , Y Shaped Genmab , Private Securities Litigation Reform Act , Quarterly Reports , Largeb Cell Lymphoma , Research Foundation ,